|
Orthologous residues
|
|
CDK16 (human): S119‑p, CDK16 iso3 (human): S193‑p, CDK16 (mouse): S119‑p, CDK16 (rat): S119‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site
|
|
Disease tissue studied:
neuroblastoma
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), CHO (fibroblast) [EphB1 (human), transfection], COS (fibroblast), HeLa (cervical), Neuro-2A (neuron)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
hamster, human, monkey
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cytoskeletal reorganization
|
|
Modification regulates interactions with:
|
|
|